Isscr 2020 Virtual

Total Page:16

File Type:pdf, Size:1020Kb

Isscr 2020 Virtual DISCOVERY POSTER ABSTRACT STARTS HERE GUIDE #ISSCR2020 23–27 JUNE 2020 ISSCR 2020 CO-SPONSORED BY: VIRTUAL THE GLOBAL STEM CELL EVENT TABLE OF CONTENTS Theme: Tissue Stem Cells and THURSDAY, JUNE 25, 2020 Regeneration Adipose and Connective Tissue ....................................................................61 POSTER SESSION I Cardiac ..................................................................................................................63 14:00 – 16:00 Early embryo .......................................................................................................64 Theme: Cellular Identity Endodermal lineage- Pancreas, Liver, Kidney ..........................................65 Cardiac .....................................................................................................................5 Epithelial ............................................................................................................... 67 Early embryo ..........................................................................................................6 Eye and Retina ...................................................................................................69 Endodermal lineage- Pancreas, Liver, Kidney .............................................7 Hematopoietic system ..................................................................................... 70 Epithelial ..................................................................................................................8 Immune system .................................................................................................. 73 Hematopoietic system ........................................................................................9 Musculoskeletal ................................................................................................. 74 Immune system .....................................................................................................9 Neural .................................................................................................................... 75 Musculoskeletal ..................................................................................................10 New Technologies ............................................................................................ 76 Neural ...................................................................................................................... 11 Placenta and Umbilical Cord Derived Cells ..............................................80 New Technologies ............................................................................................. 12 Placenta and Umbilical Cord Derived Cells ...............................................16 POSTER SESSION II 22:00 – 23:59 Theme: Clinical Applications Cardiac ...................................................................................................................16 Theme: Cellular Identity Early embryo ........................................................................................................ 17 Cardiac ................................................................................................................... 81 Endodermal lineage- Pancreas, Liver, Kidney ........................................... 17 Early embryo .......................................................................................................82 Epithelial ................................................................................................................19 Endodermal lineage- Pancreas, Liver, Kidney ..........................................85 Ethical, Legal and Social Issues; Education and Outreach ...................20 Epithelial ...............................................................................................................86 Eye and Retina ...................................................................................................20 Eye and Retina ................................................................................................... 87 Germline ................................................................................................................ 21 Germline ............................................................................................................... 87 Hematopoietic system .....................................................................................22 Hematopoietic system .....................................................................................88 Immune system ..................................................................................................22 Immune system ..................................................................................................88 Neural .................................................................................................................... 23 Musculoskeletal .................................................................................................90 New Technologies ............................................................................................ 24 Neural .....................................................................................................................91 Placenta and Umbilical Cord Derived Cells ..............................................29 New Technologies ............................................................................................92 Theme: Modeling Development and Theme: Clinical Applications Disease Adipose and Connective Tissue ...................................................................94 Early embryo .......................................................................................................95 Adipose and Connective Tissue ...................................................................30 Endodermal lineage- Pancreas, Liver, Kidney ..........................................95 Cardiac ..................................................................................................................30 Epithelial ...............................................................................................................96 Endodermal lineage- Pancreas, Liver, Kidney .......................................... 35 Eye and Retina ................................................................................................... 97 Epithelial ............................................................................................................... 38 Hematopoietic system ..................................................................................... 97 Eye and Retina ................................................................................................... 42 Neural ....................................................................................................................98 Hematopoietic system ..................................................................................... 44 New Technologies .......................................................................................... 100 Immune system ..................................................................................................45 Placenta and Umbilical Cord Derived Cells .............................................103 Musculoskeletal .................................................................................................46 Neural ....................................................................................................................46 Theme: Modeling Development and New Technologies ............................................................................................59 Disease Cardiac .................................................................................................................103 1 TABLE OF CONTENTS Early embryo ..................................................................................................... 105 Cardiac .................................................................................................................163 Endodermal lineage- Pancreas, Liver, Kidney ........................................ 106 Endodermal lineage- Pancreas, Liver, Kidney .........................................165 Endothelial Cells and Hemangioblasts ..................................................... 109 Ethical, Legal and Social Issues; Education and Outreach ................. 166 Epithelial ...............................................................................................................110 Eye and Retina ................................................................................................. 166 Eye and Retina ...................................................................................................112 Hematopoietic system ....................................................................................168 Hematopoietic system .....................................................................................113 Immune system .................................................................................................168 Immune system ..................................................................................................115 Musculoskeletal ............................................................................................... 169 Musculoskeletal .................................................................................................115 Neural .................................................................................................................
Recommended publications
  • Interplay Between Epigenetics and Metabolism in Oncogenesis: Mechanisms and Therapeutic Approaches
    OPEN Oncogene (2017) 36, 3359–3374 www.nature.com/onc REVIEW Interplay between epigenetics and metabolism in oncogenesis: mechanisms and therapeutic approaches CC Wong1, Y Qian2,3 and J Yu1 Epigenetic and metabolic alterations in cancer cells are highly intertwined. Oncogene-driven metabolic rewiring modifies the epigenetic landscape via modulating the activities of DNA and histone modification enzymes at the metabolite level. Conversely, epigenetic mechanisms regulate the expression of metabolic genes, thereby altering the metabolome. Epigenetic-metabolomic interplay has a critical role in tumourigenesis by coordinately sustaining cell proliferation, metastasis and pluripotency. Understanding the link between epigenetics and metabolism could unravel novel molecular targets, whose intervention may lead to improvements in cancer treatment. In this review, we summarized the recent discoveries linking epigenetics and metabolism and their underlying roles in tumorigenesis; and highlighted the promising molecular targets, with an update on the development of small molecule or biologic inhibitors against these abnormalities in cancer. Oncogene (2017) 36, 3359–3374; doi:10.1038/onc.2016.485; published online 16 January 2017 INTRODUCTION metabolic genes have also been identified as driver genes It has been appreciated since the early days of cancer research mutated in some cancers, such as isocitrate dehydrogenase 1 16 17 that the metabolic profiles of tumor cells differ significantly from and 2 (IDH1/2) in gliomas and acute myeloid leukemia (AML), 18 normal cells. Cancer cells have high metabolic demands and they succinate dehydrogenase (SDH) in paragangliomas and fuma- utilize nutrients with an altered metabolic program to support rate hydratase (FH) in hereditary leiomyomatosis and renal cell 19 their high proliferative rates and adapt to the hostile tumor cancer (HLRCC).
    [Show full text]
  • A Computational Approach for Defining a Signature of Β-Cell Golgi Stress in Diabetes Mellitus
    Page 1 of 781 Diabetes A Computational Approach for Defining a Signature of β-Cell Golgi Stress in Diabetes Mellitus Robert N. Bone1,6,7, Olufunmilola Oyebamiji2, Sayali Talware2, Sharmila Selvaraj2, Preethi Krishnan3,6, Farooq Syed1,6,7, Huanmei Wu2, Carmella Evans-Molina 1,3,4,5,6,7,8* Departments of 1Pediatrics, 3Medicine, 4Anatomy, Cell Biology & Physiology, 5Biochemistry & Molecular Biology, the 6Center for Diabetes & Metabolic Diseases, and the 7Herman B. Wells Center for Pediatric Research, Indiana University School of Medicine, Indianapolis, IN 46202; 2Department of BioHealth Informatics, Indiana University-Purdue University Indianapolis, Indianapolis, IN, 46202; 8Roudebush VA Medical Center, Indianapolis, IN 46202. *Corresponding Author(s): Carmella Evans-Molina, MD, PhD ([email protected]) Indiana University School of Medicine, 635 Barnhill Drive, MS 2031A, Indianapolis, IN 46202, Telephone: (317) 274-4145, Fax (317) 274-4107 Running Title: Golgi Stress Response in Diabetes Word Count: 4358 Number of Figures: 6 Keywords: Golgi apparatus stress, Islets, β cell, Type 1 diabetes, Type 2 diabetes 1 Diabetes Publish Ahead of Print, published online August 20, 2020 Diabetes Page 2 of 781 ABSTRACT The Golgi apparatus (GA) is an important site of insulin processing and granule maturation, but whether GA organelle dysfunction and GA stress are present in the diabetic β-cell has not been tested. We utilized an informatics-based approach to develop a transcriptional signature of β-cell GA stress using existing RNA sequencing and microarray datasets generated using human islets from donors with diabetes and islets where type 1(T1D) and type 2 diabetes (T2D) had been modeled ex vivo. To narrow our results to GA-specific genes, we applied a filter set of 1,030 genes accepted as GA associated.
    [Show full text]
  • NATURAL KILLER CELLS, HYPOXIA, and EPIGENETIC REGULATION of HEMOCHORIAL PLACENTATION by Damayanti Chakraborty Submitted to the G
    NATURAL KILLER CELLS, HYPOXIA, AND EPIGENETIC REGULATION OF HEMOCHORIAL PLACENTATION BY Damayanti Chakraborty Submitted to the graduate degree program in Pathology and Laboratory Medicine and the Graduate Faculty of the University of Kansas in partial fulfillment ofthe requirements for the degree of Doctor of Philosophy. ________________________________ Chair: Michael J. Soares, Ph.D. ________________________________ Jay Vivian, Ph.D. ________________________________ Patrick Fields, Ph.D. ________________________________ Soumen Paul, Ph.D. ________________________________ Michael Wolfe, Ph.D. ________________________________ Adam J. Krieg, Ph.D. Date Defended: 04/01/2013 The Dissertation Committee for Damayanti Chakraborty certifies that this is the approved version of the following dissertation: NATURAL KILLER CELLS, HYPOXIA, AND EPIGENETIC REGULATION OF HEMOCHORIAL PLACENTATION ________________________________ Chair: Michael J. Soares, Ph.D. Date approved: 04/01/2013 ii ABSTRACT During the establishment of pregnancy, uterine stromal cells differentiate into decidual cells and recruit natural killer (NK) cells. These NK cells are characterized by low cytotoxicity and distinct cytokine production. In rodent as well as in human pregnancy, the uterine NK cells peak in number around mid-gestation after which they decline. NK cells associate with uterine spiral arteries and are implicated in pregnancy associated vascular remodeling processes and potentially in modulating trophoblast invasion. Failure of trophoblast invasion and vascular remodeling has been shown to be associated with pathological conditions like preeclampsia syndrome, hypertension in mother and/or fetal growth restriction. We hypothesize that NK cells fundamentally contribute to the organization of the placentation site. In order to study the in vivo role of NK cells during pregnancy, gestation stage- specific NK cell depletion was performed in rats using anti asialo GM1 antibodies.
    [Show full text]
  • Supplementary Table S4. FGA Co-Expressed Gene List in LUAD
    Supplementary Table S4. FGA co-expressed gene list in LUAD tumors Symbol R Locus Description FGG 0.919 4q28 fibrinogen gamma chain FGL1 0.635 8p22 fibrinogen-like 1 SLC7A2 0.536 8p22 solute carrier family 7 (cationic amino acid transporter, y+ system), member 2 DUSP4 0.521 8p12-p11 dual specificity phosphatase 4 HAL 0.51 12q22-q24.1histidine ammonia-lyase PDE4D 0.499 5q12 phosphodiesterase 4D, cAMP-specific FURIN 0.497 15q26.1 furin (paired basic amino acid cleaving enzyme) CPS1 0.49 2q35 carbamoyl-phosphate synthase 1, mitochondrial TESC 0.478 12q24.22 tescalcin INHA 0.465 2q35 inhibin, alpha S100P 0.461 4p16 S100 calcium binding protein P VPS37A 0.447 8p22 vacuolar protein sorting 37 homolog A (S. cerevisiae) SLC16A14 0.447 2q36.3 solute carrier family 16, member 14 PPARGC1A 0.443 4p15.1 peroxisome proliferator-activated receptor gamma, coactivator 1 alpha SIK1 0.435 21q22.3 salt-inducible kinase 1 IRS2 0.434 13q34 insulin receptor substrate 2 RND1 0.433 12q12 Rho family GTPase 1 HGD 0.433 3q13.33 homogentisate 1,2-dioxygenase PTP4A1 0.432 6q12 protein tyrosine phosphatase type IVA, member 1 C8orf4 0.428 8p11.2 chromosome 8 open reading frame 4 DDC 0.427 7p12.2 dopa decarboxylase (aromatic L-amino acid decarboxylase) TACC2 0.427 10q26 transforming, acidic coiled-coil containing protein 2 MUC13 0.422 3q21.2 mucin 13, cell surface associated C5 0.412 9q33-q34 complement component 5 NR4A2 0.412 2q22-q23 nuclear receptor subfamily 4, group A, member 2 EYS 0.411 6q12 eyes shut homolog (Drosophila) GPX2 0.406 14q24.1 glutathione peroxidase
    [Show full text]
  • 1714 Gene Comprehensive Cancer Panel Enriched for Clinically Actionable Genes with Additional Biologically Relevant Genes 400-500X Average Coverage on Tumor
    xO GENE PANEL 1714 gene comprehensive cancer panel enriched for clinically actionable genes with additional biologically relevant genes 400-500x average coverage on tumor Genes A-C Genes D-F Genes G-I Genes J-L AATK ATAD2B BTG1 CDH7 CREM DACH1 EPHA1 FES G6PC3 HGF IL18RAP JADE1 LMO1 ABCA1 ATF1 BTG2 CDK1 CRHR1 DACH2 EPHA2 FEV G6PD HIF1A IL1R1 JAK1 LMO2 ABCB1 ATM BTG3 CDK10 CRK DAXX EPHA3 FGF1 GAB1 HIF1AN IL1R2 JAK2 LMO7 ABCB11 ATR BTK CDK11A CRKL DBH EPHA4 FGF10 GAB2 HIST1H1E IL1RAP JAK3 LMTK2 ABCB4 ATRX BTRC CDK11B CRLF2 DCC EPHA5 FGF11 GABPA HIST1H3B IL20RA JARID2 LMTK3 ABCC1 AURKA BUB1 CDK12 CRTC1 DCUN1D1 EPHA6 FGF12 GALNT12 HIST1H4E IL20RB JAZF1 LPHN2 ABCC2 AURKB BUB1B CDK13 CRTC2 DCUN1D2 EPHA7 FGF13 GATA1 HLA-A IL21R JMJD1C LPHN3 ABCG1 AURKC BUB3 CDK14 CRTC3 DDB2 EPHA8 FGF14 GATA2 HLA-B IL22RA1 JMJD4 LPP ABCG2 AXIN1 C11orf30 CDK15 CSF1 DDIT3 EPHB1 FGF16 GATA3 HLF IL22RA2 JMJD6 LRP1B ABI1 AXIN2 CACNA1C CDK16 CSF1R DDR1 EPHB2 FGF17 GATA5 HLTF IL23R JMJD7 LRP5 ABL1 AXL CACNA1S CDK17 CSF2RA DDR2 EPHB3 FGF18 GATA6 HMGA1 IL2RA JMJD8 LRP6 ABL2 B2M CACNB2 CDK18 CSF2RB DDX3X EPHB4 FGF19 GDNF HMGA2 IL2RB JUN LRRK2 ACE BABAM1 CADM2 CDK19 CSF3R DDX5 EPHB6 FGF2 GFI1 HMGCR IL2RG JUNB LSM1 ACSL6 BACH1 CALR CDK2 CSK DDX6 EPOR FGF20 GFI1B HNF1A IL3 JUND LTK ACTA2 BACH2 CAMTA1 CDK20 CSNK1D DEK ERBB2 FGF21 GFRA4 HNF1B IL3RA JUP LYL1 ACTC1 BAG4 CAPRIN2 CDK3 CSNK1E DHFR ERBB3 FGF22 GGCX HNRNPA3 IL4R KAT2A LYN ACVR1 BAI3 CARD10 CDK4 CTCF DHH ERBB4 FGF23 GHR HOXA10 IL5RA KAT2B LZTR1 ACVR1B BAP1 CARD11 CDK5 CTCFL DIAPH1 ERCC1 FGF3 GID4 HOXA11 IL6R KAT5 ACVR2A
    [Show full text]
  • Electronic Supplementary Material (ESI) for Metallomics
    Electronic Supplementary Material (ESI) for Metallomics. This journal is © The Royal Society of Chemistry 2018 Uniprot Entry name Gene names Protein names Predicted Pattern Number of Iron role EC number Subcellular Membrane Involvement in disease Gene ontology (biological process) Id iron ions location associated 1 P46952 3HAO_HUMAN HAAO 3-hydroxyanthranilate 3,4- H47-E53-H91 1 Fe cation Catalytic 1.13.11.6 Cytoplasm No NAD biosynthetic process [GO:0009435]; neuron cellular homeostasis dioxygenase (EC 1.13.11.6) (3- [GO:0070050]; quinolinate biosynthetic process [GO:0019805]; response to hydroxyanthranilate oxygenase) cadmium ion [GO:0046686]; response to zinc ion [GO:0010043]; tryptophan (3-HAO) (3-hydroxyanthranilic catabolic process [GO:0006569] acid dioxygenase) (HAD) 2 O00767 ACOD_HUMAN SCD Acyl-CoA desaturase (EC H120-H125-H157-H161; 2 Fe cations Catalytic 1.14.19.1 Endoplasmic Yes long-chain fatty-acyl-CoA biosynthetic process [GO:0035338]; unsaturated fatty 1.14.19.1) (Delta(9)-desaturase) H160-H269-H298-H302 reticulum acid biosynthetic process [GO:0006636] (Delta-9 desaturase) (Fatty acid desaturase) (Stearoyl-CoA desaturase) (hSCD1) 3 Q6ZNF0 ACP7_HUMAN ACP7 PAPL PAPL1 Acid phosphatase type 7 (EC D141-D170-Y173-H335 1 Fe cation Catalytic 3.1.3.2 Extracellular No 3.1.3.2) (Purple acid space phosphatase long form) 4 Q96SZ5 AEDO_HUMAN ADO C10orf22 2-aminoethanethiol dioxygenase H112-H114-H193 1 Fe cation Catalytic 1.13.11.19 Unknown No oxidation-reduction process [GO:0055114]; sulfur amino acid catabolic process (EC 1.13.11.19) (Cysteamine
    [Show full text]
  • Epigenetic Regulation of Endothelial-Cell-Mediated Vascular Repair Sylvain Fraineau1,2,3, Carmen G
    REVIEW ARTICLE Epigenetic regulation of endothelial-cell-mediated vascular repair Sylvain Fraineau1,2,3, Carmen G. Palii1,3, David S. Allan1 and Marjorie Brand1,2,3 1 Sprott Center for Stem Cell Research, Regenerative Medicine Program, Ottawa Hospital Research Institute, Canada 2 Department of Cellular and Molecular Medicine, University of Ottawa, Canada 3 Ottawa Institute of Systems Biology, Canada Keywords Maintenance of vascular integrity is essential for the prevention of vascular DNA methylation; endothelial progenitors; disease and for recovery following cardiovascular, cerebrovascular and epigenetics; epigenetic drugs; histone peripheral vascular events including limb ischemia, heart attack and stroke. acetylation; histone methylation; non-coding Endothelial stem/progenitor cells have recently gained considerable interest RNAs; stem cell therapy; transcription factors; vascular ischemic disease due to their potential use in stem cell therapies to mediate revascularization after ischemic injury. Therefore, there is an urgent need to understand fun- Correspondence damental mechanisms regulating vascular repair in specific cell types to M. Brand, Sprott Center for Stem Cell develop new beneficial therapeutic interventions. In this review, we high- Research, Regenerative Medicine Program, light recent studies demonstrating that epigenetic mechanisms (including Ottawa Hospital Research Institute, Ottawa post-translational modifications of DNA and histones as well as non-cod- ON K1H8L6, Canada ing RNA-mediated processes) play essential roles in the regulation of endo- Fax: +1 613 739 6294 Tel: +1 613 737 7700 ext. 70336 thelial stem/progenitor cell functions through modifying chromatin E-mail: [email protected] structure. Furthermore, we discuss the potential of using small molecules that modulate the activities of epigenetic enzymes to enhance the vascular (Received 21 October 2014, revised 17 repair function of endothelial cells and offer insight on potential strategies December 2014, accepted 19 December that may accelerate clinical applications.
    [Show full text]
  • Brigitte M. Jockusch Editor the Actin Cytoskeleton Handbook of Experimental Pharmacology
    Handbook of Experimental Pharmacology 235 Brigitte M. Jockusch Editor The Actin Cytoskeleton Handbook of Experimental Pharmacology Volume 235 Editor-in-Chief James E. Barrett, Philadelphia Editorial Board V. Flockerzi, Homburg M.A. Frohman, Stony Brook, NY P. Geppetti, Florence F.B. Hofmann, Mu¨nchen M.C. Michel, Mainz C.P. Page, London W. Rosenthal, Berlin K. Wang, Beijing More information about this series at http://www.springer.com/series/164 Brigitte M. Jockusch Editor The Actin Cytoskeleton Editor Brigitte M. Jockusch Cell Biology, Life Sciences BRICS, TU Braunschweig Braunschweig, Germany ISSN 0171-2004 ISSN 1865-0325 (electronic) Handbook of Experimental Pharmacology ISBN 978-3-319-46369-8 ISBN 978-3-319-46371-1 (eBook) DOI 10.1007/978-3-319-46371-1 Library of Congress Control Number: 2016963070 # Springer International Publishing AG 2017 This work is subject to copyright. All rights are reserved by the Publisher, whether the whole or part of the material is concerned, specifically the rights of translation, reprinting, reuse of illustrations, recitation, broadcasting, reproduction on microfilms or in any other physical way, and transmission or information storage and retrieval, electronic adaptation, computer software, or by similar or dissimilar methodology now known or hereafter developed. The use of general descriptive names, registered names, trademarks, service marks, etc. in this publication does not imply, even in the absence of a specific statement, that such names are exempt from the relevant protective laws and regulations and therefore free for general use. The publisher, the authors and the editors are safe to assume that the advice and information in this book are believed to be true and accurate at the date of publication.
    [Show full text]
  • Ipsc Australia Inc
    IPSC AUSTRALIA INC. INTRODUCTORY SAFETY AND HOLSTER PROFICIENCY COURSE 2004 Introductory Safety & Holster Proficiency Course © IPSC AUSTRALIA Inc. 2004 IPSC Australia Inc: Introductory Safety and Holster Proficiency Course TABLE OF CONTENTS 1 INTRODUCTION.................................................................................................................................... 3 1.1 Course safety rules....................................................................................................................................4 1.2 Course outline ...........................................................................................................................................4 1.3 History of IPSC ..........................................................................................................................................5 1.4 Structure of IPSC Australia........................................................................................................................6 2 SAFETY.................................................................................................................................................. 8 2.1 General......................................................................................................................................................8 2.2 Three fundamentals of gun control ..........................................................................................................10 2.3 Safety in the classroom ...........................................................................................................................10
    [Show full text]
  • Destination Liverpool
    One University More than 120 countries Over 3,500 online graduates t with an experience to share h What’s your story? g i s UNIVERSITY OF LIVERPOOL AUTUMN 201 0 n i Destination P R O D U C T I O N : U N I V E R Liverpool S I T Y C O The changing face of the city R P O R A T E C O M M U N I C A T I O N S P R I N T E D O N R E C Y C L E D P A Share your experience of studying online, your P E R . P L graduation, and where your degree has taken you E . A S E R E C Capture your story in a short video as part of our Y C L E T competition. H I S D O C U M E N Visit www.ohecampus.com for more information. T PRINTED ON: EVOLUTION SATIN MADE FROM 75% RECYCLED FIBRE (NAPM CERTIFIED) AND CYCLUS OFFSET MADE FROM 100% RECYCLED FIBRE. t THE FIRST WELCOME h WORD FROM THE VC g i s Welcome to the autumn 2010 edition Geneva and also here in the UK. It has been of insight. It is an interesting time for wonderful to witness the continued enthusiasm n and support from alumni for their alma mater, i the University as cuts in Government funding mean that the higher education as well as their desire to be kept up to date sector is about to go through a great with what is happening in the city.
    [Show full text]
  • Art of Shooting Art of Shooting an Introduction to Target Shooting with Rifle, Pistol, Shotgun and Airgun
    Art of Shooting Art of Shooting An introduction to target shooting with rifle, pistol, shotgun and airgun Prof. Philip Treleaven Preface This handbook is a ‘primer’ for the new target shooter: introducing the firearms, shooting disciplines and firearm technology, and drawing on the expertise of Bisley, the home of British and Commonwealth target shooting. For someone interested in taking up target shooting, it is surprisingly difficult to find out what are the different shooting disciplines (or to give them their ISSF name Events), and perhaps more importantly what’s available in their area. Naturally you won’t find Shooting for Dummies in the local bookshop, but there are some excellent books and web sites, especially in the United States. Most cater for the experienced competitor in a specific discipline, like Smallbore or Benchrest, rather than the new shooter. I am fortunate in that I live 40 minutes drive from the world famous Bisley Camp, the home of British and Commonwealth shooting (cf. Camp Perry in America). The great thing about shooting at Bisley is the wealth of knowledge and experience available covering all aspects of the sport. People who have shot in the Olympics and Commonwealth Games, national champions for every shooting discipline, experts in ballistics and hand loading, gunsmiths and armourers … and national coaches. Truly a university of shooting – akin to Cambridge or Harvard! However, even at Bisley it is a daunting challenge to find out what shooting disciplines are available, and who to ask for advice. It’s like everyone else in the shooting world knows everything about shooting, marksmanship, ballistics and hand loading, and you the novice know nothing.
    [Show full text]
  • 1986 V39 07 Jul.Pdf
    <. - 0 .. (..., .. L; -. .-- SLY % AUSTRALIAN 1 AUSTRALIA5 BIGGEST SPONSOR f OF CLAY Tmn"' Two masterpieces from Belgium New Browning B125 - A perfect combination of exotic walnut and forged steel wrought into classic sporting and old English game guns. The B125, crafted with traditional Browning skill, is the direct descendant of one of the most beautiful and robust guns ever created - 4 the legendary masterpiece John Moses Browning invented in 1926.,, 1 ( to the Belgian engravers. The whole act~onis finished in "Old SHOTSHEU!j Silver': Beautifully designed Game Scenes Browning Promax are depict pheasants and ducks on either srde. again available in It is complemented by fine hand cut Australia, imported from c the famous Belgium works. The Wad is unique; designed for perfect seal. Shot collar gives consistent patterns. The extra hard Shot is highly polished and graphited to ensure ~V&W Choke. excellent enetration. This interchangeable choke can be The ~wvd)eris selected changed in seconds yet is ~nvisiblefrom the for optimum ballistics side. Perfect sighting without distraction. Five chokes available. Game model features English Gooseneck stock and also available in 1/4-3/4 and %-F, fixed choke. Ask at your gun dealer. M06121985 Dealer Enquiries: FULLER FIREARMS GROUP PTY LTD., GPO Box 1096, Sydney, NSW 2001. - --- --- Achampion gun built by champion gun makers with the most up-to-date know-how and high technology and modern advantages to make you as elevated as the gun itself. If you are thinking of a new gun - IMMEDIATELY THINK: I We have the best and also the expertise to recommend your requirements.
    [Show full text]